Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, ...

Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...

Earnings call Heron Therapeutics reported Q1 2026 net sales of $34.7M, impacted by severe winter weather and seasonal headwinds, but maintained strong YoY growth in its acute care portfolio (32%).

Except as required by law, Heron assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so. And with that, I would now ...

Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.01772, expectations were $-0.03. Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 ...